McKesson Corporation (LON:0JZU)
708.87
-4.33 (-0.61%)
At close: May 1, 2025
McKesson Revenue
McKesson had revenue of $95.29B USD in the quarter ending December 31, 2024, with 17.80% growth. This brings the company's revenue in the last twelve months to $344.58B, up 14.29% year-over-year. In the fiscal year ending March 31, 2024, McKesson had annual revenue of $308.95B with 11.65% growth.
Revenue (ttm)
$344.58B
Revenue Growth
+14.29%
P/S Ratio
0.24
Revenue / Employee
$6.76M
Employees
51,000
Market Cap
67.00B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 308.95B | 32.24B | 11.65% |
Mar 31, 2023 | 276.71B | 12.75B | 4.83% |
Mar 31, 2022 | 263.97B | 25.74B | 10.80% |
Mar 31, 2021 | 238.23B | 7.18B | 3.11% |
Mar 31, 2020 | 231.05B | 16.73B | 7.81% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
McKesson News
- 15 hours ago - McKesson Corporation Declares Quarterly Dividend - Business Wire
- 2 days ago - Baron Health Care Fund Q1 2025 Top Net Purchases And Sales - Seeking Alpha
- 7 days ago - McKesson Shares Rise Nearly 1% After Key Signal - Benzinga
- 7 days ago - McKesson Shares Rise Nearly 1% After Key Signal - Benzinga
- 15 days ago - McKesson Unveils Precision Care Companion, Revolutionizing Precision Medicine in Community Oncology - Business Wire
- 22 days ago - These 20 stocks have risen during Trump's trade tirade. Analysts see up to 30% additional upside. - Market Watch
- 23 days ago - Registration Opens for Annual McKesson ideaShare Conference - Business Wire
- 24 days ago - Sit Out The Crash With These 5 Dividend Stocks - Benzinga